The Evolving Ms Landscape: Challenges and Opportunities

Summary of Presentations from the Genzyme-Sponsored Symposium, held at the Joint Congress of European Neurology (EFNS-ENS), Istanbul, Turkey, on 2nd June 2014

Chairperson: Mefkûre Eraksoy1
Speakers: Mefkûre Eraksoy,1 Matthias Mäurer,2 Alastair Compston3

1. Department of Neurology, Istanbul Faculty of Medicine and University of Istanbul, Istanbul, Turkey
2. Department of Neurology, Caritas-Hospital Bad Mergentheim, Bad Mergentheim, Germany
3. Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK

Disclosure: Prof Eraksoy has received honoraria, educational grants, and consults from: Biogen, Teva Turkey, Gen Pharma, Bayer Healthcare, Merck Serono, Novartis, and Genzyme. Prof Mäurer has received honoraria, travel grants, and speaker fees from: Biogen Idec, Novartis, Teva, Genzyme, Merck Serono, Boehringer, and Bayer. Prof Compston is a scientific adviser to Lundbeck and has received lecture fees (on behalf of himself and the University of Cambridge); Cambridge University has received endowment for a senior academic position from Genzyme.
Acknowledgements: Writing assistance provided by Dr Tom Priddle.
Support: The publication of this article was funded by Genzyme. The views and opinions expressed are those of the authors and not necessarily of Genzyme.
Citation: EMJ Neurol. 2014;1:36-42.

Download (PDF, 82KB)

Comments are closed.